|
Stephen J. Fanning was appointed President and Chief Executive Officer of Thermage, Inc. on January 15, 2005 and Chairman of the Board of Directors effective as of July 31, 2006. Mr. Fanning joined Thermage, Inc. from Ocular Sciences, Inc., a $350 million global public company, which developed, manufactured and marketed disposable contact lenses. Mr. Fanning had been President and Chief Executive Officer of the Company and a member of the Board of Directors since August 13, 2001. Under his leadership, Ocular Sciences implemented a next-generation manufacturing process significantly driving down the cost of goods sold, achieved significant increases in global market share and attained more than $300 million in annual sales. In January 2005, Ocular Sciences was successfully acquired by CooperVision for $1.3 billion. Mr. Fanning joined Ocular Sciences from Johnson & Johnson (J&J), one of the world's largest manufacturers of healthcare products, where he served in various senior executive positions of escalating responsibility for 25 years. His most recent position was President, Worldwide, of J&J's McNeil Specialty Products division. Prior to that, he served as President of Johnson & Johnson Medical, a medical device company. Mr. Fanning has also served as Managing Director of J&J Austria/Switzerland, and Vice President, Sales, of J&J's McNeil Consumer Products Division. Mr. Fanning holds a Bachelor of Science degree from Philadelphia University. | 